Pediatrics open science
Estimated SARS-CoV-2 Seroprevalence Among Children: United States, September 2021 to December 2022
Par Bratcher A, Deng Y, Deng X et 10 autres.
Contenu en anglais
Résumé
Background
Studying seroprevalence, the prevalence of SARS-CoV-2 antibodies in blood, produces more reliable estimates of infection burden compared with diagnosed cases. In this analysis, United States Nationwide Commercial Laboratory Seroprevalence Study data are used to calculate pediatric seroprevalence trends and their correlation with state-level vaccination.